Literature DB >> 2785920

Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. I. Definitions, methods, psychopathological and social outcome.

A Marneros1, A Deister, A Rohde, E M Steinmeyer, H Jünemann.   

Abstract

The long-term outcome of 72 schizoaffective and 97 schizophrenic patients with a mean duration of illness of 25.6 years and 19.6 years respectively was investigated. The outcome was assessed using the WHO Disability Assessment Schedule (WHO/DAS), the Psychological Impairment Rating Schedule (PIRS) (also developed by the WHO), the Global Assessment Scale (GAS), and the Bonn Psychopathological Criteria of Outcome. The outcome of schizoaffective disorders was found to differ from that of schizophrenia in several ways: (a) schizoaffectives achieve a full remission significantly more frequently than schizophrenics (50% vs 10%); (b) the development of so-called characteristic schizophrenic residua is the exception in schizoaffective disorders, but is frequent in schizophrenia; (c) disability, psychological impairment and disturbances of the level of functioning are not only significantly less frequent in schizoaffective disorders but are also less intense than in the schizophrenic group. The factors influencing the outcome of the two disorders are different (see part II), as are the social consequences (part III).

Entities:  

Mesh:

Year:  1989        PMID: 2785920     DOI: 10.1007/bf00450998

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  25 in total

1.  The WHO Psychological Impairments Rating Schedule (WHO/PIRS). I. Introducing a new instrument for rating observed behaviour and the rationale of the psychological impairment concept.

Authors:  H Biehl; K Maurer; A Jablensky; J E Cooper; T Tomov
Journal:  Br J Psychiatry Suppl       Date:  1989-11

2.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

3.  Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. II. Causal-analytical investigations.

Authors:  E M Steinmeyer; A Marneros; A Deister; A Rohde; H Jünemann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

4.  Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. III. Social consequences.

Authors:  A Marneros; E M Steinmeyer; A Deister; A Rohde; H Jünemann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

5.  Long-term course of schizoaffective disorders. Part I: Definitions, methods, frequency of episodes and cycles.

Authors:  A Marneros; A Deister; A Rohde; H Jünemann; R Fimmers
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

6.  The offspring of schizophrenics.

Authors:  M Bleuler
Journal:  Schizophr Bull       Date:  1974       Impact factor: 9.306

7.  How serious is schizophrenia? Comments on prognosis.

Authors:  C M Harding; J S Strauss
Journal:  Biol Psychiatry       Date:  1984-12       Impact factor: 13.382

8.  Measurement of social disability in a schizophrenic patient group. Definition, assessment and outcome over 2 years in a cohort of schizophrenic patients of recent onset.

Authors:  C Schubart; B Krumm; H Biehl; R Schwarz
Journal:  Soc Psychiatry       Date:  1986

9.  "Schizoaffective disorder": an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder.

Authors:  H G Pope; J F Lipinski; B M Cohen; D T Axelrod
Journal:  Am J Psychiatry       Date:  1980-08       Impact factor: 18.112

10.  Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5-8 year follow-up.

Authors:  H J Möller; W Schmid-Bode; C Cording-Tömmel; H U Wittchen; M Zaudig; D von Zerssen
Journal:  Acta Psychiatr Scand       Date:  1988-04       Impact factor: 6.392

View more
  14 in total

Review 1.  [Deconstructing schizophrenia. Dimensional models or division into subtypes?].

Authors:  M Jäger; K Frasch; F U Lang; T Becker
Journal:  Nervenarzt       Date:  2012-03       Impact factor: 1.214

Review 2.  Recovery in schizophrenia: reality or mere slogan.

Authors:  Natalie B Slopen; Patrick W Corrigan
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

3.  Unipolar and bipolar schizoaffective disorders: a comparative study. I. Premorbid and sociodemographic features.

Authors:  A Marneros; A Deister; A Rohde
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

4.  Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. II. Causal-analytical investigations.

Authors:  E M Steinmeyer; A Marneros; A Deister; A Rohde; H Jünemann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

5.  Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. III. Social consequences.

Authors:  A Marneros; E M Steinmeyer; A Deister; A Rohde; H Jünemann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

6.  The costs of schizophrenia in Puerto Rico.

Authors:  M Rubio-Stipec; B Stipec; G Canino
Journal:  J Ment Health Adm       Date:  1994

7.  Subtypes in schizophrenic disorders: frequencies in long-term course and premorbid features.

Authors:  A Deister; A Marneros
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1993-08       Impact factor: 4.328

8.  Long-term stability of subtypes in schizophrenic disorders: a comparison of four diagnostic systems.

Authors:  A Deister; A Marneros
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

9.  Schizoaffective disorder: clinical aspects, differential diagnosis, and treatment.

Authors:  Andreas Marneros
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

10.  Evidence for separate diseases?: Stages of one disease or different combinations of symptom dimensions?

Authors:  Heinz Häfner; Wolfram an der Heiden; Kurt Maurer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.